Bionano Genomics, Inc. (BNGO)
USD 4.11
(1.45%)
USD 4.11
(1.45%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -6.81 USD | -48.69% |
| 2022 | -4.58 USD | -74.81% |
| 2021 | -2.62 USD | 33.67% |
| 2020 | -3.95 USD | 80.17% |
| 2019 | -19.92 USD | 23.79% |
| 2018 | -26.14 USD | 69.78% |
| 2017 | -86.50 USD | -139.88% |
| 2016 | -36.06 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.24 USD | 59.98% |
| 2024 Q1 | -0.60 USD | 37.5% |
| 2023 Q3 | -3.22 USD | -159.68% |
| 2023 FY | - USD | -48.69% |
| 2023 Q4 | -0.96 USD | 70.19% |
| 2023 Q1 | -1.23 USD | 5.38% |
| 2023 Q2 | -1.24 USD | -0.81% |
| 2022 Q4 | -1.30 USD | -18.18% |
| 2022 Q1 | -1.05 USD | -29.63% |
| 2022 Q3 | -1.10 USD | 2.65% |
| 2022 FY | - USD | -74.81% |
| 2022 Q2 | -1.13 USD | -7.62% |
| 2021 Q3 | -0.74 USD | -5.71% |
| 2021 Q4 | -0.81 USD | -9.46% |
| 2021 FY | - USD | 33.67% |
| 2021 Q1 | -0.38 USD | 66.37% |
| 2021 Q2 | -0.70 USD | -84.21% |
| 2020 FY | - USD | 80.17% |
| 2020 Q1 | -2.95 USD | -4.24% |
| 2020 Q2 | -0.89 USD | 69.83% |
| 2020 Q3 | -0.81 USD | 8.99% |
| 2020 Q4 | -1.13 USD | -39.51% |
| 2019 FY | - USD | 23.79% |
| 2019 Q4 | -2.83 USD | 51.79% |
| 2019 Q3 | -5.87 USD | 16.86% |
| 2019 Q2 | -7.06 USD | 8.19% |
| 2019 Q1 | -7.69 USD | -20.53% |
| 2018 Q1 | -7.36 USD | -551.33% |
| 2018 Q2 | -9.84 USD | -33.7% |
| 2018 FY | - USD | 69.78% |
| 2018 Q3 | -6.33 USD | 35.67% |
| 2018 Q4 | -6.38 USD | -0.79% |
| 2017 FY | - USD | -139.88% |
| 2017 Q1 | -10.88 USD | 0.0% |
| 2017 Q2 | -1.28 USD | 88.24% |
| 2017 Q3 | -9.73 USD | -660.16% |
| 2017 Q4 | -1.13 USD | 88.39% |
| 2016 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -1.27 USD | -436.22% |
| Applied DNA Sciences, Inc. | -15.21 USD | 55.227% |
| Aspira Women's Health Inc. | -1.81 USD | -276.243% |
| Biodesix, Inc. | -0.64 USD | -964.063% |
| BioNexus Gene Lab Corp. | -0.17 USD | -3905.882% |
| bioAffinity Technologies, Inc. | -0.91 USD | -648.352% |
| bioAffinity Technologies, Inc. | -0.91 USD | -648.352% |
| CareDx, Inc | -3.54 USD | -92.373% |
| Check-Cap Ltd. | -3.00 USD | -127.0% |
| Castle Biosciences, Inc. | -2.14 USD | -218.224% |
| DarioHealth Corp. | -1.93 USD | -252.85% |
| Exact Sciences Corporation | -1.13 USD | -502.655% |
| Fulgent Genetics, Inc. | -5.63 USD | -20.959% |
| Guardant Health, Inc. | -4.28 USD | -59.112% |
| ICON Public Limited Company | 7.46 USD | 191.287% |
| IDEXX Laboratories, Inc. | 10.17 USD | 166.962% |
| Illumina, Inc. | -7.35 USD | 7.347% |
| Intelligent Bio Solutions Inc. | -6.38 USD | -6.74% |
| iSpecimen Inc. | -1.23 USD | -453.659% |
| Standard BioTools Inc. | -0.94 USD | -624.468% |
| MDxHealth SA | -1.66 USD | -310.241% |
| 23andMe Holding Co. | -1.40 USD | -386.429% |
| Medpace Holdings, Inc. | 9.20 USD | 174.022% |
| Myriad Genetics, Inc. | -1.39 USD | -389.928% |
| Mainz Biomed B.V. | -1.62 USD | -320.37% |
| ENDRA Life Sciences Inc. | -1.11 USD | -513.514% |
| NeoGenomics, Inc. | -0.70 USD | -872.857% |
| Neogen Corporation | -0.04 USD | -15555.172% |
| Inotiv, Inc. | -4.10 USD | -66.098% |
| Natera, Inc. | -3.78 USD | -80.159% |
| OpGen, Inc. | -41.47 USD | 83.578% |
| OPKO Health, Inc. | -0.25 USD | -2624.0% |
| Psychemedics Corporation | -0.72 USD | -845.833% |
| Prenetics Global Limited | -5.58 USD | -22.043% |
| Prenetics Global Limited | -5.58 USD | -22.043% |
| Precipio, Inc. | -4.51 USD | -50.998% |
| Personalis, Inc. | -2.25 USD | -202.667% |
| RadNet, Inc. | 0.05 USD | 14317.119% |
| Sera Prognostics, Inc. | -1.16 USD | -487.069% |
| Sotera Health Company | 0.18 USD | 3883.333% |
| Neuronetics, Inc. | -1.05 USD | -548.571% |
| Star Equity Holdings, Inc. | 7.42 USD | 191.779% |
| Star Equity Holdings, Inc. | 7.42 USD | 191.779% |
| Trinity Biotech plc | -3.14 USD | -116.879% |
| T2 Biosystems, Inc. | -19.19 USD | 64.513% |
| Twist Bioscience Corporation | -3.60 USD | -89.167% |
| Exagen Inc. | -1.34 USD | -408.209% |